<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Nehasoni1234 - Latest News</title>
<link href="https://news.prfree.org/rss/nehasoni1234/latest.xml"></link>
<updated>2026-07-19T22:01:20+00:00</updated>
<id>urn:uuid:c69d5d3c-7857-fdc8-f1df-703381813ee3</id>
<entry>
<title>Healthcare Analytics Market |Analysis, Trends, New Business Opportunities and Forecast to 2022 – 2026</title>
<link href="https://news.prfree.org/@nehasoni1234/healthcare-analytics-market-analysis-trends-new-business-opportunities-and-forecast-to-2022-2026-w7w9lc94vum6"></link>
<id>urn:uuid:a037997b-66d9-5890-8bd0-072e73812f91</id>
<summary type="html"><![CDATA[Healthcare Analytics Market by Type (Descriptive, Prescriptive, Cognitive), Application (Financial, Operational, RCM, Fraud, Clinical), Component (Services, Hardware), Deployment (On-premise, Cloud), End-user (Providers, Payer) (2022 - 2026)]]></summary>
<updated>2022-09-19T14:24:27+00:00</updated>
</entry>
<entry>
<title>Global Vaccines Market Forecast 2022 – 2026| Key Players - GlaxoSmithKline Plc (UK), Merck &amp; Co., Inc. (US), Sanofi SA (France), and Pfizer, Inc. (US)</title>
<link href="https://news.prfree.org/@nehasoni1234/global-vaccines-market-forecast-2022-2026-key-players-glaxosmithkline-plc-uk-merck-co-inc-us-sanofi-sa-france-and-pfizer-inc-us-9bi9lr0tkye5"></link>
<id>urn:uuid:1f3110aa-b4ae-61a2-47d7-a31fe6947061</id>
<summary type="html"><![CDATA[The Global Vaccines Market is projected to reach USD 67.2 billion by 2026, at a CAGR of 10.2%. The global vaccines market (including COVID-19 vaccines) is projected to reach USD 149.2 billion by 2026 during the forecast period]]></summary>
<updated>2022-09-15T06:26:02+00:00</updated>
</entry>
</feed>